Insider transactions

EDGAR

Atea Pharmaceuticals, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
1 transactions, 6,100 shares
Sum of shares × price per share: 25,446.15
Open-market sales (code S)
3 transactions, 41,226 shares
Sum of shares × price per share: 168,094.9506

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 71

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-18 Filed 2026-11-18Polsky Bruce Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)18,2521.24
22,632.48

Derived: shares × price per share. Exact value 22632.48.

176,832Direct (D) No— Open filing 0001193125-26-467490 Read from the filing’s XML Dispute this row
2026-11-18 Filed 2026-11-18Polsky Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)18,2523.9502
72,099.0504

Derived: shares × price per share. Exact value 72099.0504.

158,580Direct (D) No
F3
  • F3 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.91 to $4.00. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-467490 Read from the filing’s XML Dispute this row
2026-11-18 Filed 2026-11-18Polsky Bruce Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (18,252) — exercise price 1.24
Disposed (D)18,2520—0Direct (D) No
F4
  • F4 The option is fully vested and exercisable.
Open filing 0001193125-26-467490 Read from the filing’s XML Dispute this row
2026-11-17 Filed 2026-11-18Polsky Bruce Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)8,7201.24
10,812.8

Derived: shares × price per share. Exact value 10812.80.

167,300Direct (D) No— Open filing 0001193125-26-467490 Read from the filing’s XML Dispute this row
2026-11-17 Filed 2026-11-18Polsky Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,7204.0316
35,155.552

Derived: shares × price per share. Exact value 35155.5520.

158,580Direct (D) No
F2
  • F2 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.00 to $4.10. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-467490 Read from the filing’s XML Dispute this row
2026-11-17 Filed 2026-11-18Polsky Bruce Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (8,720) — exercise price 1.24
Disposed (D)8,7200—18,252Direct (D) No
F4
  • F4 The option is fully vested and exercisable.
Open filing 0001193125-26-467490 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-18Polsky Bruce Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)48,0281.24
59,554.72

Derived: shares × price per share. Exact value 59554.72.

172,834Direct (D) No— Open filing 0001193125-26-467490 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-18Polsky Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)14,2544.2683
60,840.3482

Derived: shares × price per share. Exact value 60840.3482.

158,580Direct (D) No
F1
  • F1 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.20 to $4.33. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-467490 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-18Polsky Bruce Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (48,028) — exercise price 1.24
Disposed (D)48,0280—26,972Direct (D) No
F4
  • F4 The option is fully vested and exercisable.
Open filing 0001193125-26-467490 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Murphy Polly A. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)29,6000—121,745Direct (D) No
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
Open filing 0001193125-26-279718 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Murphy Polly A. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (29,600)
Disposed (D)29,6000—0Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F2 The RSUs vested in full on June 18, 2026.
Open filing 0001193125-26-279718 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Murphy Polly A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (26,700)
Acquired (A)26,7000—26,700Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F3 The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001193125-26-279718 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Murphy Polly A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (37,700) — exercise price 4.36
Acquired (A)37,7000—37,700Direct (D) No
F4
  • F4 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Open filing 0001193125-26-279718 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Lucidi Bruno Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)29,6000—142,350Direct (D) No
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
Open filing 0001193125-26-279728 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Lucidi Bruno Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (29,600)
Disposed (D)29,6000—0Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F2 The RSUs vested in full on June 18, 2026.
Open filing 0001193125-26-279728 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Lucidi Bruno Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (26,700)
Acquired (A)26,7000—26,700Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F3 The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001193125-26-279728 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Lucidi Bruno Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (37,700) — exercise price 4.36
Acquired (A)37,7000—37,700Direct (D) No
F4
  • F4 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Open filing 0001193125-26-279728 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Adams Jerome M. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)29,6000—92,350Direct (D) No
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
Open filing 0001193125-26-279720 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Adams Jerome M. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (29,600)
Disposed (D)29,6000—0Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F2 The RSUs vested in full on June 18, 2026.
Open filing 0001193125-26-279720 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Adams Jerome M. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (26,700)
Acquired (A)26,7000—26,700Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F3 The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001193125-26-279720 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Adams Jerome M. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (37,700) — exercise price 4.36
Acquired (A)37,7000—37,700Direct (D) No
F4
  • F4 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Open filing 0001193125-26-279720 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Polsky Bruce Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)29,6000—124,806Direct (D) No
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
Open filing 0001193125-26-279719 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Polsky Bruce Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (29,600)
Disposed (D)29,6000—0Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F2 The RSUs vested in full on June 18, 2026.
Open filing 0001193125-26-279719 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Polsky Bruce Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (26,700)
Acquired (A)26,7000—26,700Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F3 The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001193125-26-279719 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Polsky Bruce Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (37,700) — exercise price 4.36
Acquired (A)37,7000—37,700Direct (D) No
F4
  • F4 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Open filing 0001193125-26-279719 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23BERGER FRANKLIN M Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)29,6000—536,097Direct (D) No
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
Open filing 0001193125-26-279726 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23BERGER FRANKLIN M Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (29,600)
Disposed (D)29,6000—0Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F2 The RSUs vested in full on June 18, 2026.
Open filing 0001193125-26-279726 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23BERGER FRANKLIN M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (26,700)
Acquired (A)26,7000—26,700Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F3 The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001193125-26-279726 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23BERGER FRANKLIN M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (37,700) — exercise price 4.36
Acquired (A)37,7000—37,700Direct (D) No
F4
  • F4 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Open filing 0001193125-26-279726 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23DUNCAN BARBARA GAYLE Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)29,6000—92,350Direct (D) No
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
Open filing 0001193125-26-279721 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23DUNCAN BARBARA GAYLE Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (29,600)
Disposed (D)29,6000—0Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F2 The RSUs vested in full on June 18, 2026.
Open filing 0001193125-26-279721 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23DUNCAN BARBARA GAYLE Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (26,700)
Acquired (A)26,7000—26,700Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F3 The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001193125-26-279721 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23DUNCAN BARBARA GAYLE Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (37,700) — exercise price 4.36
Acquired (A)37,7000—37,700Direct (D) No
F4
  • F4 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Open filing 0001193125-26-279721 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Berman Howard Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (26,700)
Acquired (A)26,7000—26,700Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F2 The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001193125-26-279723 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23Berman Howard Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (37,700) — exercise price 4.36
Acquired (A)37,7000—37,700Direct (D) No
F3
  • F3 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Open filing 0001193125-26-279723 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23KIRSCH ARTHUR S Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (26,700)
Acquired (A)26,7000—26,700Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F2 The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001193125-26-279717 Read from the filing’s XML Dispute this row
2026-06-18 Filed 2026-06-23KIRSCH ARTHUR S Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (37,700) — exercise price 4.36
Acquired (A)37,7000—37,700Direct (D) No
F3
  • F3 The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Open filing 0001193125-26-279717 Read from the filing’s XML Dispute this row
2026-05-18 Filed 2026-05-21Murphy Polly A. Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)6,1004.1715
25,446.15

Derived: shares × price per share. Exact value 25446.1500.

92,145Direct (D) No
F1, F2
  • F1 This Form 4/A has been filed solely to correct the date of the transaction reported in Column 2 of Table I of the Reporting Person's Form 4 filed on May 20, 2026, which was inadvertently noted as May 18, 2025 instead of May 18, 2026.
  • F2 The price reported in Column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $4.14 to $4.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-235039 Read from the filing’s XML Dispute this row
2026-03-11 Filed 2026-03-13Corcoran Andrea Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)60,0001.24
74,400

Derived: shares × price per share. Exact value 74400.00.

823,576Direct (D) No— Open filing 0001193125-26-106547 Read from the filing’s XML Dispute this row
2026-03-11 Filed 2026-03-13Corcoran Andrea Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (60,000) — exercise price 1.24
Acquired (A)60,0000—0Direct (D) No
F1
  • F1 The option is fully vested and exercisable.
Open filing 0001193125-26-106547 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-03Sommadossi Jean-Pierre Director · Officer: President, CEO, and Chairman
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)300,0001.24
372,000

Derived: shares × price per share. Exact value 372000.00.

767,830Direct (D) No— Open filing 0001193125-26-036268 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-03Sommadossi Jean-Pierre Director · Officer: President, CEO, and Chairman
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (300,000) — exercise price 1.24
Disposed (D)300,0000—0Direct (D) No
F5
  • F5 The option is fully vested and exercisable.
Open filing 0001193125-26-036268 Read from the filing’s XML Dispute this row
2026-01-31 Filed 2026-02-03Corcoran Andrea Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)54,866——779,680Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F2 Includes 7,507 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan.
Open filing 0001193125-26-036269 Read from the filing’s XML Dispute this row
2026-01-31 Filed 2026-02-03Corcoran Andrea Officer: See Remarks
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)16,1044.24
68,280.96

Derived: shares × price per share. Exact value 68280.96.

763,576Direct (D) No— Open filing 0001193125-26-036269 Read from the filing’s XML Dispute this row
2026-01-31 Filed 2026-02-03Corcoran Andrea Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (44,366)
Disposed (D)44,3660—0Direct (D) No
F1, F3
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F3 The original grant of 133,100 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026.
Open filing 0001193125-26-036269 Read from the filing’s XML Dispute this row
2026-01-31 Filed 2026-02-03Corcoran Andrea Officer: See Remarks
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (10,500)
Disposed (D)10,5000—0Direct (D) No
F1, F4
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F4 Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026.
Open filing 0001193125-26-036269 Read from the filing’s XML Dispute this row
2026-01-31 Filed 2026-02-03Corcoran Andrea Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (180,000) — exercise price 4.24
Acquired (A)180,0000—180,000Direct (D) No
F5
  • F5 The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030.
Open filing 0001193125-26-036269 Read from the filing’s XML Dispute this row
2026-01-31 Filed 2026-02-03Horga Maria Arantxa Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)51,283——112,159Direct (D) No
F1
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
Open filing 0001193125-26-036281 Read from the filing’s XML Dispute this row
2026-01-31 Filed 2026-02-03Horga Maria Arantxa Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)16,0734.24
68,149.52

Derived: shares × price per share. Exact value 68149.52.

96,086Direct (D) No— Open filing 0001193125-26-036281 Read from the filing’s XML Dispute this row
2026-01-31 Filed 2026-02-03Horga Maria Arantxa Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (41,533)
Disposed (D)41,5330—0Direct (D) No
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
  • F2 The original grant of 124,600 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026.
Open filing 0001193125-26-036281 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–50 of 135

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
FMR LLC Partly reported under another manager12,030,704 SH62,679,968 dollarsHigher by 26,640 Prior quarter: 12,004,064Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
BlackRock, Inc. Partly reported under another manager9,061,530 SH47,210,571 dollarsHigher by 341,453 Prior quarter: 8,720,077Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
BML Capital Management, LLC 6,753,658 SH35,186,558 dollarsLower by 198,672 Prior quarter: 6,952,330Open filing 0001754960-26-000981 Filed 2026-11-06 Dispute this row
TANG CAPITAL MANAGEMENT LLC Partly reported under another manager4,814,700 SH25,084,587 dollarsUnchanged Prior quarter: 4,814,700Open filing 0001214659-26-014410 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 2,906,793 SH15,144,392 dollarsLower by 58,069 Prior quarter: 2,964,862Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager2,338,271 SH12,174 dollarsHigher by 303,079 Prior quarter: 2,035,192Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
Bain Capital Life Sciences Investors, LLC 2,075,639 SH10,814,079 dollarsUnchanged Prior quarter: 2,075,639Open filing 0001193125-26-462089 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,910,289 SH9,955,072 dollarsLower by 48,146 Prior quarter: 1,958,435Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
STATE STREET CORP Partly reported under another manager1,626,938 SH8,476,347 dollarsLower by 25,461 Prior quarter: 1,652,399Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
TWO SIGMA INVESTMENTS, LP 1,303,341 SH6,790,407 dollarsLower by 203,356 Prior quarter: 1,506,697Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager1,300,324 SH6,774,503 dollarsHigher by 809 Prior quarter: 1,299,515Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager1,092,900 SH5,694,009 dollarsLower by 38,300 Prior quarter: 1,131,200Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager925,284 SH4,792,972 dollarsLower by 20,634 Prior quarter: 945,918Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager715,769 SH3,729,156 dollarsLower by 39,470 Prior quarter: 755,239Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 639,968 SH3,334,233 dollarsHigher by 9,783 Prior quarter: 630,185Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 637,551 SH3,321,641 dollarsHigher by 26,944 Prior quarter: 610,607Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Ikarian Capital, LLC Option: Call 614,500 SH3,201,545 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager556,469 SH2,899,204 dollarsLower by 163,045 Prior quarter: 719,514Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager493,689 SH2,572,120 dollarsHigher by 245,979 Prior quarter: 247,710Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager477,579 SH2,488,186 dollarsLower by 53,277 Prior quarter: 530,856Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 469,723 SH2,447,257 dollarsLower by 78 Prior quarter: 469,801Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
CM Management, LLC 450,000 SH2,344,500 dollarsHigher by 95,000 Prior quarter: 355,000Open filing 0001841857-26-000004 Filed 2026-11-12 Dispute this row
Rock Springs Capital Management LP 433,620 SH2,259,160 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005279 Filed 2026-11-16 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager353,494 SH1,841,704 dollarsHigher by 8,308 Prior quarter: 345,186Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
BANQUE PICTET CIE SA 345,077 SH1,797,851 dollarsUnchanged Prior quarter: 345,077Open filing 0001535602-26-000012 Filed 2026-10-16 Dispute this row
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Partly reported under another manager322,668 SH1,681,100 dollarsHigher by 112,126 Prior quarter: 210,542Open filing 0001164508-26-000060 Filed 2026-11-13 Dispute this row
Rosalind Advisors, Inc. 280,061 SH1,459,118 dollarsLower by 790,489 Prior quarter: 1,070,550Open filing 0001622627-26-000034 Filed 2026-11-16 Dispute this row
Invesco Ltd. Partly reported under another manager254,337 SH1,325,095 dollarsLower by 12,788 Prior quarter: 267,125Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Quantinno Capital Management LP 251,935 SH1,312,581 dollarsHigher by 9,633 Prior quarter: 242,302Open filing 0001759654-26-000011 Filed 2026-11-13 Dispute this row
Nuveen, LLC Partly reported under another manager247,657 SH1,290,293 dollarsLower by 36,626 Prior quarter: 284,283Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager246,582 SH1,284,692 dollarsHigher by 39,797 Prior quarter: 206,785Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager245,456 SH1,278,826 dollarsHigher by 231,746 Prior quarter: 13,710Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
HSBC HOLDINGS PLC Partly reported under another manager240,650 SH1,256,193 dollarsHigher by 19,641 Prior quarter: 221,009Open filing 0000873630-26-000005 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager196,724 SH1,024,932 dollarsHigher by 7,272 Prior quarter: 189,452Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
BOOTHBAY FUND MANAGEMENT, LLC Option: Call 196,300 SH1,022,723 dollarsNot in the prior quarter’s filings read Open filing 0001549230-26-000012 Filed 2026-11-16 Dispute this row
BARCLAYS PLC Partly reported under another manager175,465 SH914,172 dollarsLower by 173,188 Prior quarter: 348,653Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Auour Investments LLC Partly reported under another manager172,000 SH896,120 dollarsLower by 5,000 Prior quarter: 177,000Open filing 0001789310-26-000004 Filed 2026-10-28 Dispute this row
STRS OHIO 171,100 SH891,431 dollarsHigher by 53,400 Prior quarter: 117,700Open filing 0000820478-26-000018 Filed 2026-10-30 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager170,291 SH887,216 dollarsLower by 366 Prior quarter: 170,657Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
MILLENNIUM MANAGEMENT LLC 159,884 SH832,996 dollarsLower by 144,727 Prior quarter: 304,611Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager147,948 SH770,809 dollarsHigher by 53,441 Prior quarter: 94,507Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
BRIDGEWAY CAPITAL MANAGEMENT, LLC 129,356 SH673,945 dollarsLower by 1,544 Prior quarter: 130,900Open filing 0001107261-26-000007 Filed 2026-11-16 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager117,720 SH613,321 dollarsLower by 6,500 Prior quarter: 124,220Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
STATE OF WISCONSIN INVESTMENT BOARD 117,357 SH611,430 dollarsLower by 1,400 Prior quarter: 118,757Open filing 0001062993-26-006051 Filed 2026-11-16 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager115,808 SH604 dollarsUnchanged Prior quarter: 115,808Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager108,838 SH567,046 dollarsHigher by 27,108 Prior quarter: 81,730Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
Empowered Funds, LLC Partly reported under another manager91,256 SH475,444 dollarsNot in the prior quarter’s filings read Open filing 0001592828-26-000008 Filed 2026-11-13 Dispute this row
RHUMBLINE ADVISERS 88,042 SH458,691 dollarsLower by 3,082 Prior quarter: 91,124Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
Aldebaran Capital, LLC 86,068 SH448,414 dollarsLower by 2,112 Prior quarter: 88,180Open filing 0001376474-26-000722 Filed 2026-11-13 Dispute this row
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. Partly reported under another manager70,000 SH364,700 dollarsUnchanged Prior quarter: 70,000Open filing 0000905148-26-004861 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Curated Wealth Partners LLC 695,000 SH
  • Sixth Street Partners Management Company, L.P. 610,607 SH
  • Opaleye Management Inc. 235,000 SH
  • Jump Financial, LLC 102,421 SH
  • ALGERT GLOBAL LLC 38,520 SH
  • Squarepoint Ops LLC 29,316 SH
  • JOHNSON INVESTMENT COUNSEL INC 25,590 SH
  • INTECH INVESTMENT MANAGEMENT LLC 16,655 SH
  • Headlands Technologies LLC 16,619 SH
  • Cerity Partners LLC 16,471 SH
  • Graham Capital Management, L.P. 16,145 SH
  • NEUBERGER BERMAN GROUP LLC 12,077 SH
  • GROUP ONE TRADING LLC 4,400 SH
  • Smartleaf Asset Management LLC 3,325 SH
  • Integrated Wealth Concepts LLC 437 SH
  • ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ 128 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.001 per share6.04,814,700.0010/06/2026 Filed 2026-10-06SCHEDULE 13GOpen filing 0001214659-26-012604 Dispute this row
KEVIN TANG Common Stock, par value $0.001 per share6.04,814,700.0010/06/2026 Filed 2026-10-06SCHEDULE 13GOpen filing 0001214659-26-012604 Dispute this row
TANG CAPITAL PARTNERS, LP Common Stock, par value $0.001 per share3.12,488,519.0010/06/2026 Filed 2026-10-06SCHEDULE 13GOpen filing 0001214659-26-012604 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.001 per share2.11,665,077.0010/06/2026 Filed 2026-10-06SCHEDULE 13GOpen filing 0001214659-26-012604 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.001 per share0.8661,104.0010/06/2026 Filed 2026-10-06SCHEDULE 13GOpen filing 0001214659-26-012604 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.001 per share0.00.0010/06/2026 Filed 2026-10-06SCHEDULE 13GOpen filing 0001214659-26-012604 Dispute this row
JPM Partners LLC Common Stock, par value $0.0016.45,116,02509/30/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 5Open filing 0001193125-26-460848 Dispute this row
Jean-Pierre Sommadossi Common Stock, par value $0.00111.09,080,45009/30/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 5Open filing 0001193125-26-460848 Dispute this row
FMR LLC COMMON STOCK15.011,950,771.8703/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 9Open filing 0000315066-26-001112 Dispute this row
Abigail P. Johnson COMMON STOCK15.011,950,771.8703/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 9Open filing 0000315066-26-001112 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 3Open filing 0000102909-26-000786 Dispute this row
BML Investment Partners, L.P. Common Stock9.67,490,00012/31/2025 Filed 2026-02-09SCHEDULE 13GOpen filing 0001373604-26-000010 Dispute this row
Leonard Braden Michael Common Stock9.97,810,00012/31/2025 Filed 2026-02-09SCHEDULE 13GOpen filing 0001373604-26-000010 Dispute this row
FMR LLC COMMON STOCK11.69,095,679.8711/28/2025 Filed 2025-12-05SCHEDULE 13G/AAmendment 8Open filing 0000315066-25-002957 Dispute this row
Abigail P. Johnson COMMON STOCK11.69,095,679.8711/28/2025 Filed 2025-12-05SCHEDULE 13G/AAmendment 8Open filing 0000315066-25-002957 Dispute this row
FMR LLC COMMON STOCK6.75,719,757.8706/30/2025 Filed 2025-08-06SCHEDULE 13G/AAmendment 7Open filing 0000315066-25-001974 Dispute this row
Abigail P. Johnson COMMON STOCK6.75,719,757.8706/30/2025 Filed 2025-08-06SCHEDULE 13G/AAmendment 7Open filing 0000315066-25-001974 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,540,664 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020166,957
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to Atea Pharmaceuticals, Inc.